Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

2022/45/B/NZ5/01695

Keywords

Descriptors

  • NZ4_002: Fizjologia
  • NZ5_007: Leczenie chorób człowieka
  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Martyna Krzykawska-Serda

Number of co-investigators in the project: 6

Call

OPUS 23 – announced on 2022-03-28

Amount awarded
2 863 143 PLN
Project start date
2023-01-23
Project end date
2028-01-22
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Pulse and CW EPR Oximetry Using Oxychip in Gemcitabine-Treated Murine Pancreatic Tumors

    Authors:
    Gabriela Dziurman, Agnieszka Drzał, Aleksandra Anna Murzyn, Maciej Mikolaj Kmiec, Martyna Elas & Martyna Krzykawska-Serda
    Academic press:
    Molecular Imaging and Biology (year: 2023, volume: 26, pages: 473–483), Publisher: Springer
    Status:
    Published
    DOI:
    10.1007/s11307-023-01859-w – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski